King Wealth Management Group
Source: SEC Form 13F · as of Mar 2026King Wealth Management Group holds 18 biotech & pharma companies tracked by BioSniper, totaling $22K in value as of Mar 2026 (SEC Form 13F).
Companies held
18
Total value held
$22K
| Company | Shares | Value |
|---|---|---|
| LLYELI LILLY & Co | 7,436 | $7K |
| JNJJOHNSON & JOHNSON | 15,318 | $4K |
| TEVATeva Pharmaceutical Industries Limited | 110,000 | $3K |
| UTHRUNITED THERAPEUTICS Corp | 4,150 | $2K |
| ABTABBOTT LABORATORIES | 11,604 | $1K |
| MRKMerck & Co., Inc. | 7,895 | $950 |
| ABBVAbbVie Inc. | 2,692 | $585 |
| PFEPFIZER INC | 19,221 | $540 |
| NVSNovartis AG | 3,200 | $489 |
| PTGXProtagonist Therapeutics, Inc | 4,000 | $422 |
| AMGNAMGEN INC | 1,176 | $414 |
| BMYBRISTOL MYERS SQUIBB CO | 6,812 | $413 |
| UNHUnitedHealth Group Incorporated Common Stock (DE) | 1,183 | $320 |
| ELVElevance Health Inc. | 1,046 | $306 |
| GILDGILEAD SCIENCES, INC. | 1,725 | $240 |
| DFTXDefinium Therapeutics Inc. | 10,000 | $189 |
| HRTXHERON THERAPEUTICS, INC. /DE/ | 32,799 | $26 |
| ALDXAldeyra Therapeutics, Inc. | 11,900 | $20 |
13F holdings reflect long positions in U.S.-listed securities as reported to the SEC. Values are point-in-time for the most recent reported quarter.